AHR and neoplasm: As IDO-induced kynurenine inhibits NK cells and CD8+ T cells via AhR activation [12], this is another route whereby O-GlcNAcylation in MSC, as well as in CSC [12], may modulate immune suppression in the tumour microenvironment.